120 related articles for article (PubMed ID: 2482952)
21. Selective agonists for substance P and neurokinin receptors.
Drapeau G; D'Orléans-Juste P; Dion S; Rhaleb NE; Rouissi NE; Regoli D
Neuropeptides; 1987 Jul; 10(1):43-54. PubMed ID: 2444902
[TBL] [Abstract][Full Text] [Related]
22. Two classes of binding sites for [3H]substance P in rat cerebral cortex.
Geraghty DP; Burcher E
Brain Res; 1993 Jan; 601(1-2):34-40. PubMed ID: 7679311
[TBL] [Abstract][Full Text] [Related]
23. Effects of neonatal monosodium glutamate treatment on substance P binding sites in the rat retina.
Lee CM; Cheung WT
Neurosci Lett; 1988 Oct; 92(3):310-4. PubMed ID: 2462198
[TBL] [Abstract][Full Text] [Related]
24. Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors.
Petitet F; Beaujouan JC; Saffroy M; Torrens Y; Chassaing G; Lavielle S; Besseyre J; Garret C; Carruette A; Glowinski J
J Neurochem; 1991 Mar; 56(3):879-89. PubMed ID: 1704425
[TBL] [Abstract][Full Text] [Related]
25. Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action.
Jacques L; Couture R; Drapeau G; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):170-9. PubMed ID: 2478892
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.
Guard S; Watson SP; Maggio JE; Too HP; Watling KJ
Br J Pharmacol; 1990 Apr; 99(4):767-73. PubMed ID: 1694464
[TBL] [Abstract][Full Text] [Related]
27. Radioligand binding, autoradiographic and functional studies demonstrate tachykinin NK-2 receptors in dog urinary bladder.
Mussap CJ; Stamatakos C; Burcher E
J Pharmacol Exp Ther; 1996 Oct; 279(1):423-34. PubMed ID: 8859022
[TBL] [Abstract][Full Text] [Related]
28. Gastric chief cells possess NK1 receptors which mediate pepsinogen secretion and are regulated by agents that increase cAMP and phospholipase C.
Kitsukawa Y; Turner RJ; Pradhan TK; Jensen RT
Biochim Biophys Acta; 1996 Jun; 1312(2):105-16. PubMed ID: 8672532
[TBL] [Abstract][Full Text] [Related]
29. An isolated growth cone-enriched fraction from developing rat brain has substance P binding sites.
Lockerbie RO; Beaujouan JC; Saffroy M; Glowinski J
Brain Res; 1988 May; 468(1):1-9. PubMed ID: 2454147
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic characterization of the novel ligand [4,5-3H-Leu9]neurokinin-A binding to NK-2 receptors on hamster urinary bladder membranes.
Aharony D; Conner GE; Woodhouse DP
Neuropeptides; 1992 Oct; 23(2):121-30. PubMed ID: 1333574
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand.
Laufer R; Gilon C; Chorev M; Selinger Z
J Biol Chem; 1986 Aug; 261(22):10257-63. PubMed ID: 2426259
[TBL] [Abstract][Full Text] [Related]
32. [125I]-Bolton-Hunter scyliorhinin II: a novel, selective radioligand for the tachykinin NK3 receptor in rat brain.
Mussap CJ; Burcher E
Peptides; 1990; 11(4):827-36. PubMed ID: 2172946
[TBL] [Abstract][Full Text] [Related]
33. Neurokinin receptors and mucosal ion transport in porcine jejunum.
Parsons AM; Seybold VS; Chandan R; Vogt J; Larson AA; Murray CR; Soldani G; Brown DR
J Pharmacol Exp Ther; 1992 Jun; 261(3):1213-21. PubMed ID: 1376358
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of a novel, selective radioligand, [125I][Lys5,Tyr(I2)7,MeLeu9,Nle10]neurokinin A-(4-10), for the tachykinin NK2 receptor in rat fundus.
Burcher E; Badgery-Parker T; Zeng XP; Lavielle S
Eur J Pharmacol; 1993 Mar; 233(2-3):201-7. PubMed ID: 8385622
[TBL] [Abstract][Full Text] [Related]
35. Antagonists that demonstrate species differences in neurokinin-1 receptors.
Appell KC; Fragale BJ; Loscig J; Singh S; Tomczuk BE
Mol Pharmacol; 1992 Apr; 41(4):772-8. PubMed ID: 1373802
[TBL] [Abstract][Full Text] [Related]
36. Binding sites for [125I]-Bolton-Hunter scyliorhinin II in guinea-pig ileum: a radioligand binding, functional and autoradiographic study.
Mussap CJ; Burcher E
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):301-9. PubMed ID: 7824047
[TBL] [Abstract][Full Text] [Related]
37. Specific [125I]Bolton-Hunter substance P binding sites in human and rat skin.
Deguchi M; Niwa M; Shigematsu K; Fujii T; Namba K; Ozaki M
Neurosci Lett; 1989 May; 99(3):287-92. PubMed ID: 2471120
[TBL] [Abstract][Full Text] [Related]
38. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi.
Naline E; Devillier P; Drapeau G; Toty L; Bakdach H; Regoli D; Advenier C
Am Rev Respir Dis; 1989 Sep; 140(3):679-86. PubMed ID: 2476956
[TBL] [Abstract][Full Text] [Related]
39. Radioligand binding and functional characterisation of tachykinin receptors in chicken small intestine.
Liu L; Burcher E
Naunyn Schmiedebergs Arch Pharmacol; 2001 Oct; 364(4):305-13. PubMed ID: 11683517
[TBL] [Abstract][Full Text] [Related]
40. Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.
Devillier P; Acker GM; Advenier C; Marsac J; Regoli D; Frossard N
J Pharmacol Exp Ther; 1992 Nov; 263(2):767-72. PubMed ID: 1279160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
